Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
$3.34
-7.2%
$2.73
$2.07
$4.20
$107.59M0.34100,236 shs166,862 shs
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
$4.39
-2.9%
$3.87
$2.49
$8.54
$410.74M2.25894,819 shs1.37 million shs
Organogenesis Holdings Inc. stock logo
ORGO
Organogenesis
$3.07
-3.2%
$3.77
$2.28
$6.71
$389.44M1.631.16 million shs494,797 shs
SIGA Technologies, Inc. stock logo
SIGA
SIGA Technologies
$6.36
-1.2%
$5.97
$4.95
$12.83
$454.37M0.93732,852 shs502,959 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
+5.57%+26.76%+34.83%+21.62%+36.36%
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
-1.53%-0.22%+15.90%+29.89%-33.92%
Organogenesis Holdings Inc. stock logo
ORGO
Organogenesis
-2.46%+10.07%+0.63%-36.73%+20.08%
SIGA Technologies, Inc. stock logo
SIGA
SIGA Technologies
+1.58%+9.52%+8.42%+15.41%-18.27%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
3.4243 of 5 stars
3.65.00.00.02.53.30.0
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
2.6299 of 5 stars
3.53.00.00.03.30.80.6
Organogenesis Holdings Inc. stock logo
ORGO
Organogenesis
4.6198 of 5 stars
3.33.00.04.34.24.20.6
SIGA Technologies, Inc. stock logo
SIGA
SIGA Technologies
2.4619 of 5 stars
0.03.00.00.02.70.83.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
3.25
Buy$9.00169.46% Upside
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
3.00
Buy$18.83329.01% Upside
Organogenesis Holdings Inc. stock logo
ORGO
Organogenesis
2.50
Moderate Buy$5.5079.15% Upside
SIGA Technologies, Inc. stock logo
SIGA
SIGA Technologies
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ANIX, CMPS, ORGO, and SIGA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/10/2025
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
5/29/2025
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
5/27/2025
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight$12.00
5/13/2025
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/12/2025
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$45.00 ➝ $45.00
4/10/2025
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00 ➝ $10.00
3/28/2025
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
3/26/2025
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00 ➝ $10.00
3/25/2025
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$7.00 ➝ $7.00
3/21/2025
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$10.00
(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
$210K512.31N/AN/A$0.59 per share5.66
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
N/AN/AN/AN/A$3.65 per shareN/A
Organogenesis Holdings Inc. stock logo
ORGO
Organogenesis
$458.76M0.85$0.20 per share15.72$2.11 per share1.45
SIGA Technologies, Inc. stock logo
SIGA
SIGA Technologies
$120.33M3.78$1.00 per share6.34$2.77 per share2.30
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
-$12.55M-$0.38N/AN/AN/A-58.55%-53.29%N/A
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
-$118.46M-$1.99N/AN/AN/AN/A-63.85%-51.97%7/30/2025 (Estimated)
Organogenesis Holdings Inc. stock logo
ORGO
Organogenesis
$4.95M-$0.17N/AN/AN/A-1.62%-2.69%-1.63%8/6/2025 (Estimated)
SIGA Technologies, Inc. stock logo
SIGA
SIGA Technologies
$68.07M$0.675.305.09N/A49.33%49.06%38.72%7/30/2025 (Estimated)

Latest ANIX, CMPS, ORGO, and SIGA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/3/2025Q2 2025
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
-$0.10-$0.09+$0.01-$0.09N/AN/A
5/8/2025Q1 2025
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
-$0.47-$0.44+$0.03-$0.24N/AN/A
5/8/2025Q1 2025
Organogenesis Holdings Inc. stock logo
ORGO
Organogenesis
$0.04-$0.13-$0.17-$0.17$90.77 million$86.69 million
5/8/2025Q1 2025
SIGA Technologies, Inc. stock logo
SIGA
SIGA Technologies
N/A-$0.01N/A-$0.01N/A$7.04 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
N/AN/AN/AN/AN/A
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
N/AN/AN/AN/AN/A
Organogenesis Holdings Inc. stock logo
ORGO
Organogenesis
N/AN/AN/AN/AN/A
SIGA Technologies, Inc. stock logo
SIGA
SIGA Technologies
N/AN/AN/AN/AN/A

Latest ANIX, CMPS, ORGO, and SIGA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/8/2025
SIGA Technologies, Inc. stock logo
SIGA
SIGA Technologies
special$0.604/29/20254/29/20255/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
N/A
8.54
8.54
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
0.15
8.91
8.91
Organogenesis Holdings Inc. stock logo
ORGO
Organogenesis
0.21
3.09
2.74
SIGA Technologies, Inc. stock logo
SIGA
SIGA Technologies
N/A
8.10
5.32

Institutional Ownership

CompanyInstitutional Ownership
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
29.13%
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
46.19%
Organogenesis Holdings Inc. stock logo
ORGO
Organogenesis
49.57%
SIGA Technologies, Inc. stock logo
SIGA
SIGA Technologies
55.40%

Insider Ownership

CompanyInsider Ownership
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
25.30%
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
3.93%
Organogenesis Holdings Inc. stock logo
ORGO
Organogenesis
33.00%
SIGA Technologies, Inc. stock logo
SIGA
SIGA Technologies
1.95%
CompanyEmployeesShares OutstandingFree FloatOptionable
Anixa Biosciences, Inc. stock logo
ANIX
Anixa Biosciences
532.21 million24.05 millionOptionable
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
12093.56 million65.51 millionOptionable
Organogenesis Holdings Inc. stock logo
ORGO
Organogenesis
950126.85 million79.33 millionOptionable
SIGA Technologies, Inc. stock logo
SIGA
SIGA Technologies
4071.44 million70.31 millionOptionable

Recent News About These Companies

Undiscovered Gems in the US Market for May 2025

New MarketBeat Followers Over Time

Media Sentiment Over Time

Anixa Biosciences stock logo

Anixa Biosciences NASDAQ:ANIX

$3.34 -0.26 (-7.22%)
Closing price 04:00 PM Eastern
Extended Trading
$3.44 +0.11 (+3.14%)
As of 04:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

COMPASS Pathways stock logo

COMPASS Pathways NASDAQ:CMPS

$4.39 -0.13 (-2.88%)
Closing price 04:00 PM Eastern
Extended Trading
$4.28 -0.11 (-2.39%)
As of 04:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Organogenesis stock logo

Organogenesis NASDAQ:ORGO

$3.07 -0.10 (-3.15%)
Closing price 04:00 PM Eastern
Extended Trading
$3.12 +0.05 (+1.63%)
As of 04:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane in which viable cells, growth factors/cytokines, and ECM proteins in the native tissue are preserved; Novachor, a chorion membrane in which viable cells, growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, cytokines, and growth factors; NuShield, dehydrated placental tissue covering amnion and chorion membranes for spongy/intermediate layer intact; and PuraPly AM, an antimicrobial barrier that enables conformability and fluid drainage. Its products also include FortiShield, a biosynthetic wound matrix for use as a temporary protective covering; PuraPly MZ, a micronized particulate version of PuraPly for the management of open wounds in the surgical setting; and CYGNUS Dual, a dehydrated placental tissue preserved to retain the ECM scaffold. The company's pipeline products include ReNu, a cryopreserved suspension used to support healing of soft tissues; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; and TransCyte, a bioengineered tissue for the treatment of partial thickness burns. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales representives and independent agencies. Organogenesis Holdings Inc. was founded in 1985 and is headquartered in Canton, Massachusetts.

SIGA Technologies stock logo

SIGA Technologies NASDAQ:SIGA

$6.36 -0.08 (-1.24%)
Closing price 04:00 PM Eastern
Extended Trading
$6.36 0.00 (-0.08%)
As of 04:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.